https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_qol 2026-01-30T10:10:08+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_qol_01 2026-01-30T10:13:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_qol_02 2026-01-30T10:12:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_qol_03 2026-01-30T10:11:33+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_qol_04 2026-01-30T10:10:49+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_qol_05 2026-01-30T10:18:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/faq 2026-02-09T11:14:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/voltaren/faq 2025-07-11T07:22:50+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/scemblix/faq 2025-09-10T00:37:54+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/tafmek/tafinlar_faq 2025-04-25T00:20:12+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/jakavi/faq 2025-07-11T07:23:47+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/sandostatin/faq 2025-04-25T00:19:50+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/leqvio/faq 2025-04-25T00:20:00+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/sandimmun/faq 2026-03-02T14:28:17+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/neoral/faq 2025-09-12T07:09:34+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/tafmek/mekinist_faq 2025-04-25T00:20:39+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_c3g 2026-04-06T09:41:44+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/revolade/faq 2025-07-11T07:22:11+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_c3g/c3g_material 2026-04-06T07:03:11+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/entresto/faq 2026-02-09T14:51:31+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/clozaril/faq 2026-02-02T08:50:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide 2026-01-30T10:25:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide_1 2026-01-30T10:13:56+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide_2 2026-01-30T10:16:10+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide_3 2026-01-30T10:18:05+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/azorga/faq 2026-02-02T08:47:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/azopt/faq 2026-01-30T10:41:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/vegamox/faq 2025-07-11T06:07:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/travatanz/faq 2025-06-17T00:03:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ilaris/faq 2026-03-02T13:00:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/faq 2025-07-11T06:23:14+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/atectura/faq 2026-01-30T10:39:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/enerzair/faq 2026-02-09T14:45:20+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ultibro/faq 2026-03-02T13:01:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/onbrez/faq 2026-03-02T13:15:18+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/seebri/faq 2025-07-01T13:01:03+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide_5 2026-01-30T10:14:32+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide_4 2026-01-30T10:15:14+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/leqvio/interview 2026-03-31T00:27:18+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/webinar-summary 2026-01-09T08:23:16+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/17 2025-07-07T06:15:58+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/18 2025-07-07T06:16:12+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/exelon_patch/faq 2026-03-02T12:58:52+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen 2026-03-26T07:34:03+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta-seminar-video 2026-01-30T10:23:33+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/package_updated_notice/2024 2026-03-25T07:04:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/lokametz_document 2025-12-23T02:01:28+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/galliapfarm_document 2025-12-23T01:57:49+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/tafmek/material 2026-03-10T07:03:59+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/web_reserve_introduction 2026-02-06T10:22:44+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/pluvicto_document 2026-03-19T00:29:00+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/pluvicto_faq 2025-10-28T07:51:25+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ritalin/faq 2025-10-01T06:17:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/certican/faq 2026-01-08T07:24:19+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/19 2025-10-20T01:40:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide_6 2026-01-30T10:12:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/about_video 2026-03-26T07:19:39+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/rltcare 2025-11-27T04:26:25+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/material 2026-03-19T00:37:16+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/understanding-symptoms 2026-02-20T00:47:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/patient-concerns 2026-02-20T00:41:56+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/patient-circumstances 2026-02-20T00:44:29+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/guideline_2018 2026-02-20T00:49:42+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/treatment-goals 2026-02-20T00:48:16+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr 2026-02-05T06:14:54+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr/clinical 2026-03-02T14:02:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/treatment-goal 2026-02-20T00:50:21+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/today 2026-02-20T00:51:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_anti-cd20 2026-01-16T05:21:22+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_anti-cd20-01 2026-01-16T05:21:03+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_anti-cd20-02 2026-01-16T05:20:47+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_anti-cd20-03 2026-01-16T05:20:33+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zometa/faq 2025-12-02T05:49:55+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/patient-concerns-realities 2026-02-20T00:40:42+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/treatment-goals-challenges 2026-02-20T00:45:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/situation-assessment-communication 2026-02-20T00:49:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/modern-treatment 2026-02-20T00:50:58+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr/feature 2026-02-05T05:57:46+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr/usage 2026-03-02T14:02:01+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_10 2026-02-05T04:55:58+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr/clinical_01 2026-02-05T06:08:06+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr/clinical_02 2026-02-05T06:09:28+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr/clinical_03 2026-02-05T06:10:33+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_11 2026-02-05T04:57:57+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_12 2026-02-05T04:59:29+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025 2026-01-08T00:08:57+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-01 2026-01-08T00:06:32+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-02 2026-01-08T00:06:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-03 2026-01-08T00:06:48+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-04 2026-01-08T00:07:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-05 2026-01-08T00:07:32+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-06 2026-01-08T00:07:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-07 2026-01-08T00:07:57+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-08 2026-01-08T00:08:32+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_pnh/pnh_behavior 2026-01-09T04:50:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_pnh/pnh_apply 2026-01-09T04:49:08+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_pnh/pnh_appoint 2026-01-09T04:50:14+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/20 2026-01-08T07:56:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/21 2026-01-08T07:57:29+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/22 2026-01-08T07:58:25+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/glivec/faq 2026-01-08T08:13:44+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_c3g/c3g_movie 2026-04-06T09:57:57+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_c3g/c3g_integrated-data-analysis 2026-04-06T08:36:12+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_c3g/c3g_disease 2026-04-06T06:59:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_c3g/c3g_study 2026-04-06T07:41:27+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_c3g/c3g_rmp 2026-04-06T08:36:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/hem_mailservice/interview_06 2026-02-13T00:37:23+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/hem_mailservice/interview_07 2026-02-13T00:35:12+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/it 2026-04-08T08:32:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/it/product 2026-04-08T08:01:23+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/it/material 2026-04-08T08:01:11+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/iv 2026-04-08T08:35:06+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/iv/product 2026-04-08T07:59:50+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/iv/crinicaltrial 2026-04-08T08:48:08+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/iv/crinicaltrial-cl101 2026-04-08T07:59:29+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/iv/crinicaltrial-lt101 2026-04-08T07:59:19+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/iv/crinicaltrial-cl304 2026-04-08T07:59:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/iv/material 2026-04-08T07:58:47+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/iv/library 2026-04-08T07:58:34+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/iv/medical_institution 2026-04-08T07:58:11+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/iv/requirement 2026-04-08T07:58:03+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/package_updated_notice/2025 2026-03-25T06:58:25+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/discontinued_list/2025 2026-03-26T00:58:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/follow-up/ondemand 2026-04-06T03:00:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/node/1 2026-04-16T01:33:09+00:00 daily 0.5 https://www.pro.novartis.com/jp-ja/products/order 2026-04-08T08:13:51+00:00 daily 0.5 https://www.pro.novartis.com/jp-ja/products/leqvio 2026-02-25T05:40:21+00:00 daily 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma 2026-04-08T08:26:54+00:00 daily 0.5 https://www.pro.novartis.com/jp-ja/sitemap.xml 2026-04-15T01:58:45+00:00